Plus, news about Retension Pharmaceuticals:
Vandria tops up Series A with another $10M: The Swiss biotech increased its round total to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Experts have identified a public health need as well as strategic opportunities for the accelerated development of function-promoting therapies for older adults -; and present
The enzyme engineering specialists at Codexis are giving up on making their own therapies, instead focusing on selling its technologies and services to customers —
What You Should Know: – A glimmer of hope emerged today for rectal cancer patients as a collaborative effort between Case Western Reserve University (CWRU),